摘要
目的:了解实施监管措施对喹诺酮类药临床应用的影响。方法:分析我院实施监管措施前、后应用喹诺酮类药的主要科室中,喹诺酮类药销售金额、销售金额占总销售金额百分比的变化情况。结合同期归档病历检查结果,评价用药是否合理。结果与结论:呼吸内科等6个科室为我院应用喹诺酮类药的主要科室;实施监管措施后,我院多数科室喹诺酮类药销售金额均减少,表明监管措施取得了一定成效。
OBJECTIVE: To evaluation the effects of the regulatory measures on the clinical application of quinolones. METHODS: The consumption sum and its proportion in the total in major clinical departments before and after the enforce- ment of the regulatory measures were analyzed, which were compared with the data from the synchronous case files so as to evaluate the rationality of the use of quinolones. RESULTS & CONCLUSION: Quinolones were predominantly used in six departments including the department of respiratory diseases. After the initiation of the regulatory measures, the consumption sum of quinolones decreased in most departments, suggesting the positive effect of the regulatory measures.
出处
《中国药房》
CAS
CSCD
北大核心
2009年第17期1300-1302,共3页
China Pharmacy
关键词
喹诺酮类药
销售金额
监管措施
Quinolones
Consumption sum
Regulatory measures